Jeffrey M. Arnold, Director

Mr. Arnold joined Astrocyte Pharmaceuticals’ Board of Directors in March 2017. He has 45 years of experience in the life science industry, including as the CEO of 4 companies and an angel investor in 7 companies with successful exits. He is currently the President of Arnold Strategies, LLC, which advises CEO’s with their growth and execution strategies, and Executive Chairman of First Light Biosciences. Since 2006, Mr. Arnold has been an angel investor with Boston Harbor Angels and Mass Medical Angels. He is a guest lecturer at the MIT Sloan School and a mentor to startup companies through the MIT Venture Mentoring Society and MIT Deshpande Center.

Previously, Mr. Arnold was Chairman of Corbus Pharmaceuticals (NASDAQ: CRBP), which has a phase II drug for orphan fibrotic diseases, and the CEO of CardioFocus, which has an endoscopic catheter for treating atrial fibrillation. He founded Cambridge Heart, Inc. and took the company public in 1996. He was also CEO of Molecular Simulations, Inc., a $200 MM supplier of software for drug design later called Accelrys. Early in his career Mr. Arnold held senior R&D and marketing positions for Becton Dickinson and Datascope Corp. Mr. Arnold graduated from MIT with a B.S. in Electrical Engineering.

By using this website, you agree to our use of cookies. We use cookies to improve your browsing experience. To learn more about the cookies we use, see our Privacy Policy.